Daiichi Sankyo Company Limited has initiated its Hokusai-VTE Cancer, a multinational study which will investigate the ef...
Tokyo: Australia's regenerative medicine company, Mesoblast Limited has announced that its allogeneic mesenchymal stem c...
Tokyo: Cambridge-based Syros Pharmaceuticals has entered into an exclusive license agreement with the Japanese oncology...
Singapore: Cellmid has signed an important option agreement with listed Japanese company Fujikura Kasei, a major suppli...
Japanese pharma major Daiichi Sankyo Company Limited has announced the completion of the merger process of its subsidiar...
New York-based Progenics Pharmaceuticals' partner Fujifilm RI Pharma Co. Ltd. (Fuji) has dosed the first patient in its ...
Japan' Daiichi Sankyo's domestic subsidiary, Daiichi Sankyo Espha Co Ltd. has obtained approval for partial changes conc...
Compared to 2011, global pharmaceutical and biotechnology sectors suffered a setback in the number of mergers and acquis...
Singapore: South Korea-based global healthcare enterprise, CHA Health Systems has inked a pact with Japanese medical cor...
Singapore: Japan's Kyowa Hakko Kirin and Bristol-Myers Squibb have entered into a clinical trial collaboration agreement...
Singapore: Japanese drugmaker Takeda has inked a 10-year pact with Japan's Kyoto University to co-develop stem cell ther...
Japan-US joint venture company WaVe Life Sciences announced that it has closed an $18 million Series A financing led by ...
Singapore: Immunogen has inked a pact with Japanese drugmaker Takeda pharmaceuticals that gives Takeda exclusive rights ...
Over the past four years, BioSpectrum Asia in association with CyberMedia Research (CMR) has been capturing the key br...
Singapore: Executive director of DIA, Mr Paul Pomerantz is quitting his position effective March 3, 2013, to assume the ...
Dotmatics, a UK-based provider of scientific informatics solutions and services, announced its extension of operations t...
Singapore: An international team of researchers at German Center for Neurodegenerative Diseases (DZNE) and Tokyo Institu...
Singapore: Japan-based drugmaker Otsuka Pharmaceutical's vasopressin V2 receptor antagonist Samsca 7.5mg tablets has bee...
